secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVRx, Inc. (CVRX)
CIK:        0001235912
Form:       8-K
Filed at:   2021-11-04T23:59:59+00:00
Accession:  0001104659-21-134411
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 1.02, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVRx reports Q3 revenue $3.4M (+241% YoY); repays $20M loan
-----------------------------------------------------------

- Q3 revenue $3.4M (241% YoY increase); U.S. HF revenue $2.5M vs $140K prior year.
- Net loss $6.1M ($0.30/share) vs $3.2M ($9.56/share) prior year; cash $170.9M.
- Fully repaid $20M Horizon loan on Nov 3, including fees total $21.3M.
- FY2021 guidance: revenue $13.3-13.9M; Q4 revenue expected $3.9-4.5M.
- Filed three PMA Supplement submissions for Barostim platform; FDA approval expected H1 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1235912/000110465921134411/0001104659-21-134411-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1235912/000110465921134411/tm2131665d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-134411

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer